Tianjin Medical University General Hospital

This study is testing whether an oral anemia medication called roxadustat can help prevent or treat muscle loss in people receiving kidney dialysis. Researchers will compare roxadustat against the standard injectable anemia treatment to see which one better improves muscle streng…

This early-stage study is testing the safety of a personalized immune cell therapy for people with multiple early-stage lung cancer tumors. Doctors will collect a patient's own tumor-fighting immune cells, grow them in a lab, and then inject them back into the patient. The main g…

This early-phase study is testing the safety of a two-part treatment for advanced lung cancer that has become resistant to standard targeted drugs. It combines a patient's own tumor-fighting immune cells (called TILs) with a newer generation of the targeted drug they were already…

This study compares two pain medications (oliceridine and sufentanil) given through patient-controlled pumps after lung surgery. The main goal is to see if one drug is better at preventing short-term pain from turning into long-term chronic pain. Researchers will follow 320 patie…